GRIN2B (Glutamate Ionotropic Receptor NMDA Type Subunit 2B) encodes the GluN2B subunit of the NMDA receptor, a glutamate-gated calcium channel critical for synaptic plasticity, learning, and memory. The NMDA receptor complex requires both GRIN1 (GluN1) and GRIN2 (GluN2A-D) subunits for functional channels. GRIN2B is predominantly expressed during early development and persists in certain brain regions including the forebrain, hippocampus, and cortex.
The GRIN2B subunit contributes to the unique pharmacological and biophysical properties of NMDA receptors:
- Calcium Permeability: NMDA receptors containing GRIN2B have high calcium permeability, enabling calcium-dependent signaling cascades essential for synaptic plasticity
- Slower Kinetics: GRIN2B-containing receptors have slower deactivation kinetics compared to GRIN2A-containing receptors
- Developmental Regulation: GRIN2B expression peaks early in development and decreases with age as GRIN2A expression increases
- Synaptic Localization: GRIN2B is primarily found at extrasynaptic and immature synapses
GRIN2B dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms:
- Synaptic Dysfunction: Aβ oligomers directly interact with NMDA receptors, causing internalization and impairment of glutamatergic signaling
- Excitotoxicity: Altered GRIN2B function contributes to calcium dysregulation and excitotoxic cell death
- Memory Deficits: NMDA receptor hypofunction, particularly involving GRIN2B, correlates with cognitive deficits in AD
- Tau Pathology: Hyperphosphorylated tau disrupts GRIN2B signaling and NMDA receptor trafficking
- Dopaminergic Modulation: GRIN2B-containing NMDA receptors are modulated by dopamine in the striatum
- Excitotoxicity: Overactivation of NMDA receptors contributes to dopaminergic neuron death
- Levodopa-Induced Dyskinesia: Enhanced GRIN2B signaling is implicated in L-DOPA-induced dyskinesias
- Motor Neuron Vulnerability: GRIN2B dysfunction contributes to excitotoxicity in motor neurons
- Glutamate Transport: Altered NMDA receptor signaling affects glutamate homeostasis
- GRIN2B Modulators: Positive allosteric modulators targeting GRIN2B are being developed for cognitive enhancement
- NMDA Receptor Antagonists: Memantine, an NMDA receptor antagonist, is approved for AD treatment
- Synaptic Protection: Maintaining proper GRIN2B function may protect against neurodegeneration
- Genetic Studies: GRIN2B polymorphisms have been associated with risk for various neuropsychiatric disorders
- Biomarkers: GRIN2B expression changes may serve as biomarkers for disease progression
- Gene Therapy: Viral vector delivery of GRIN2B modulators is being explored
GRIN2B shows region-specific expression:
- High Expression: Hippocampus (CA1, dentate gyrus), cerebral cortex (layers II-III, V), striatum
- Moderate Expression: Thalamus, olfactory bulb
- Cellular Localization: Neuronal cell bodies, dendritic spines, postsynaptic densities
GRIN2B interacts with numerous proteins:
- PSD-95: Anchors GRIN2B at postsynaptic densities
- CaMKII: Calcium/calmodulin-dependent kinase II phosphorylates GRIN2B
- SRC: Fyn kinase phosphorylates GRIN2B
- MAGUK Proteins: SAP90/PSD-95 family proteins
GRIN2B encodes the GluN2B subunit[^6]:
- Channel Properties: High calcium permeability
- Mg2+ Block: Voltage-dependent magnesium block
- Kinase Regulation: Multiple phosphorylation sites
- Splice Variants: Alternative splicing generates isoforms
Critical for learning and memory:
- LTP Induction: Essential for long-term potentiation
- LTD Induction: Mediates long-term depression
- Homeostatic Plasticity: Adjusts synaptic strength
- Calcium Signaling: Triggers downstream cascades
Explore gene expression and cell type data for GRIN2B in these authoritative brain atlas resources: